Direct Answer
Humana is the second-largest Medicare Advantage insurer in the U.S. and the most concentrated large managed care company in that market. Nearly all revenue comes from CMS premium payments for Medicare Advantage members. Stars quality ratings, CMS reimbursement rate decisions, and senior medical utilization trends are the three variables that most directly drive Humana's earnings. CenterWell, its primary care and home health subsidiary, is the company's effort to build an integrated care delivery model around its senior membership.
Company snapshot
| Field | Detail |
|---|---|
| Company | Humana Inc. |
| Ticker | HUM |
| Exchange | NYSE |
| Index | S&P 500, Wilshire 5000 |
| Sector | Health Care |
| Industry | Managed Health Care |
| Headquarters | Louisville, Kentucky, United States |
| Founded | 1961 |
| Fiscal year end | December 31 |
| SEC CIK | 0000049071 |
What Humana does
Humana Inc. is one of the largest U.S. health care companies, with a business model deeply concentrated in Medicare Advantage managed care for the senior population. The company operates through two reportable segments: Insurance and CenterWell.
Insurance segment: This is the dominant revenue driver. The Insurance segment administers Medicare Advantage health plans, Medicare Supplement (Medigap) policies, prescription drug plans (PDP), and Medicaid managed care. Medicare Advantage is the private alternative to traditional Medicare; enrollees receive comprehensive coverage (including dental, vision, hearing, and drug benefits not covered by traditional Medicare) from a private insurer like Humana, which is paid a risk-adjusted monthly premium by CMS in exchange for taking responsibility for the enrollee's covered medical costs. Humana has approximately 5 to 6 million Medicare Advantage members, making it the second-largest MA insurer after UnitedHealth Group.
CenterWell segment: CenterWell encompasses three service businesses: CenterWell Senior Primary Care (primary care clinics owned by Humana, focused on Medicare patients), CenterWell Pharmacy (mail-order and specialty pharmacy for MA members), and CenterWell Home Health (in-home health services). The CenterWell model is built around the hypothesis that deep primary care management of high-utilization senior patients reduces hospitalizations and emergency department visits, improving both health outcomes and total cost of care, thereby improving MA plan economics.
Medicare Advantage economics and Stars
Understanding Medicare Advantage economics is essential to understanding Humana. CMS pays Medicare Advantage plans a risk-adjusted benchmark premium for each enrollee, calibrated to the county in which the member resides and adjusted for the health status (risk score) of the member. Sicker, more complex members receive higher risk scores and generate higher CMS payments. The plan retains the spread between its risk-adjusted premium and its actual medical costs (the medical loss ratio, or MLR, is costs as a percentage of premium).
CMS's Stars quality rating system overlays a quality bonus on top of the base benchmark payment. Plans rated four stars or above receive bonuses that can add several hundred basis points to their effective premium rate. For Humana, with several million MA members, a Stars rating change on a large plan can shift hundreds of millions of dollars in annual bonus income. Stars ratings are determined by clinical quality metrics (breast cancer screening rates, HbA1c control in diabetics), drug safety metrics, and member satisfaction surveys. Plans that lose a major plan's Stars rating to below four stars in a given year see the bonus income disappear in the following benefit year.
The combination of CMS rate setting and Stars bonus income means that Humana's financial performance is significantly shaped by two annual government decisions: the MA rate announcement (published each spring for the following benefit year) and the Stars ratings (published each October for the following benefit year). Both are binary, externally determined events, which is why Humana's stock tends to react sharply to both.
Risks and watchlist
- MA reimbursement rate adequacy: CMS annual rate announcements can come in above or below what plans need to break even at current benefit levels. Below-expected rates force benefit reductions or market exits, directly reducing Humana's enrollment and earnings.
- Medical cost ratio pressure: Post-pandemic utilization of outpatient services, behavioral health, and high-cost specialty drugs has driven MA medical cost ratios above guidance levels across the sector. If utilization does not normalize, earnings guidance requires revision.
- Stars rating volatility: A decline in Stars ratings below four stars on a large Humana plan removes material bonus income with a one-year lag. The determinants of Stars ratings include factors Humana influences (clinical quality programs, member outreach) and factors it does not (member survey responses, which are variable).
- Concentration risk: Humana's dependence on Medicare Advantage is higher than any other large managed care company. Any adverse development specific to the MA market affects Humana more acutely than peers with more diversified insurance portfolios.
- CenterWell execution: Building owned primary care clinics and home health services requires sustained capital investment and multi-year break-even periods per clinic. If the value-based care model does not deliver the expected cost reduction for MA members, the investment thesis for CenterWell is impaired.
Frequently asked questions
What does Humana do?
Humana is a managed care organization primarily focused on Medicare Advantage health plans for Americans aged 65 and older. It is the second-largest Medicare Advantage insurer in the United States by enrollment, behind UnitedHealth Group. Humana operates through two reportable segments: Insurance (Medicare Advantage, Medicare Supplement, and Medicaid plans) and CenterWell (primary care clinics focused on senior patients, pharmacy services, and home health services). The CenterWell segment reflects Humana's strategy to build an integrated care delivery model around its Medicare Advantage membership.
How does Humana make money?
Humana generates revenue primarily from Medicare Advantage premiums. CMS pays Humana a risk-adjusted monthly premium for each Medicare Advantage enrollee; Humana is responsible for covering the enrollee's medical costs within that payment. The difference between the CMS premium received and the medical costs incurred is the insurance margin. Humana aims to manage medical costs through network contracting, utilization management, and care management programs. CenterWell generates additional revenue from primary care clinic visits, pharmacy dispensing, and home health services, with the strategic goal of using these services to improve health outcomes and reduce total cost of care for MA members.
Why is Medicare Advantage so central to Humana's investment case?
Medicare Advantage accounts for the vast majority of Humana's revenue and earnings. This makes Humana the most concentrated Medicare Advantage play among large publicly traded managed care companies. The investment thesis for high MA concentration is that the senior population is growing (approximately 10,000 Baby Boomers turn 65 each day), MA penetration of the eligible Medicare population continues to rise, and a well-managed MA plan with strong quality ratings (Stars) earns bonus payments from CMS that augment the base premium. The risk is that CMS controls the reimbursement rates, and below-expected rate increases directly reduce the profitability of Humana's entire business in a way that a more diversified managed care company would not experience.
What are CMS Stars ratings and why do they matter to Humana?
CMS rates Medicare Advantage plans on a quality scale of one to five stars, measuring metrics including chronic disease management, preventive care screenings, member satisfaction, and drug safety. Plans rated four stars or higher receive quality bonus payments from CMS, which can add several percentage points to the base premium rate. For a company as large as Humana, a shift in Stars ratings across its plan portfolio can mean hundreds of millions of dollars in annual bonus payments. When Stars ratings fall below four stars on a large plan, Humana loses that bonus income, reducing margins. Stars results are published annually and are one of the most closely watched annual events for Humana investors.
What are the main risks for Humana investors to watch?
Key risks include Medicare Advantage reimbursement rate risk (CMS sets annual benchmark payment rates; below-expected increases directly reduce profitability across Humana's entire book of business), medical cost pressure (elevated senior utilization, particularly for outpatient services and behavioral health, has driven medical cost ratios above guidance across the MA sector in 2023 to 2025), Stars quality rating volatility (a decline in Stars ratings below four stars on a large plan removes significant bonus income), regulatory risk (CMS can change MA program design, risk adjustment methodology, or plan requirements in ways that affect economics), and concentration risk (Humana is more concentrated in Medicare Advantage than any other large managed care company, meaning any adverse development in MA affects Humana more severely than more diversified peers).